Abstract
Brain disorders represent 35% of the total disease burden in Europe and 37% of the total disease burden in European regions with very low child mortality and low adult mortality; the latter group includes Italy. The negative socioeconomic impact of this burden is reflected in two fundamental issues: consumption of resources and state of health. In recent years, the European Brain Council (EBC), a co-ordinating council formed by European organisations and patient associations in neurological disorders, has encouraged and supported projects aimed at analysing the socioeconomic burden of brain disorders in Europe. Within the EBC, the pan-European study on Cost of Disorders of the Brain in Europe (CDBE) aimed at reporting the best possible estimates of the societal cost of 12 brain disorders (addiction, affective disorders, anxiety disorders, tumours, dementia, epilepsy, migraine and other headaches, multiple sclerosis, Parkinson's disease, psychotic disorders, stroke and trauma) based on the existing literature, using an ad hoc cost model. The aggregated results for Italy from the CDBE study are reviewed in this paper.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.